Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes

Autor:	Raquel Barrio-Castellanos, Pilar Isabel Beato-Víbora, María Martín-Frías, Lucía Lázaro-Martín, Francisco Javier Arroyo-Díez, Carmen Quirós-López, Estela Gil-Poch, Marga Giménez-Álvarez
Rok vydání:	2018
Předmět:	Adult Blood Glucose Male Pediatrics medicine.medical_specialty Adolescent Endocrinology Diabetes and Metabolism 030209 endocrinology & metabolism Hypoglycemia 03 medical and health sciences Young Adult 0302 clinical medicine Endocrinology Patient satisfaction Insulin Infusion Systems Diabetes mellitus medicine Humans Hypoglycemic Agents Insulin 030212 general & internal medicine Low glucose suspend Child Glycemic Retrospective Studies Type 1 diabetes Continuous glucose monitoring business.industry Blood Glucose Self-Monitoring medicine.disease Medical Laboratory Technology Diabetes Mellitus Type 1 Treatment Outcome Patient Satisfaction Female business
Zdroj:	Diabetes technologytherapeutics. 20(11)
ISSN:	1557-8593
Popis:	The aim was to evaluate the effectiveness of sensor-augmented pump therapy with predictive low-glucose suspend function (SAP-PLGS) in real-world use in children and adults with type 1 diabetes (T1D).Patients with T1D treated with the MiniMed 640GA total of 162 patients were included. Mean age was 32 ± 17 years, 28% were (n = 46) children, and 29% (n = 47) were with a history of severe hypoglycemia. Median follow-up was 12 months (6-18). HbSAP-PLGS reduces hypoglycemia frequency while maintaining glycemic control in adults and children under real-life conditions.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8925f3c44a11b6065cad15f2f7ba038 https://pubmed.ncbi.nlm.nih.gov/30256132 Zobrazit plný text záznamu